HCPCS Level IIdrugActive
J0872
Daptomycin (xellia) unrefrig
BETOS: O1E
Effective: 2024-07-01
Description
Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Daptomycin
Manufacturer
Xellia Pharmaceuticals USA, LLC.
HCPCS Dosage
1 MG
Billing Units
500.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.